These are the biggest biopharma stories we covered in 2018
A roundup of some of the biggest trends and events in pharmaceuticals, biotechnology and diagnostics in 2018, including regulatory approvals, international trends, national policy and more.
What ever happened to the NantHealth-Independence Blue Cross sequencing partnership?
In January 2016, Independence Blue Cross and NantHealth announced the nation's first coverage for a whole genome sequencing and proteome molecular diagnostic platform, but it's mostly slipped under the radar since then. What's going on?
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Soon-Shiong’s new cancer vaccine is the “culmination” of NantWorks’ science
After 15 years of research, Patrick Soon-Shiong has unveiled the Nant Cancer Vaccine, bringing together myriad biology and technology advances made throughout his NantWorks empire.
Four companies using health IT to support a genetic test management infrastructure
With genetic testing on the rise, here are some health tech companies that are building services supporting this market.
NantHealth stock soars in IPO
NantHealth, the health IT, genomics and analytics division of Dr. Patrick Soon-Shiong’s NantWorks business empire, raised $91 million in the IPO.
Morning Read: Spending on oncology drugs rises 11.5% to $107B, NantHealth prices IPO
Also, Forbes re-evaluates Theranos Founder Elizabeth Holmes' net worth, the FDA has approved the first liquid biopsy for lung cancer and Strata Oncology closed a $12 million Series A financing to advance its tumor sequencing business.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
5 must-read stories this week: NantHealth files for IPO, what are the health tech trends shaping ePRO?
Every week, we compile the most popular and thoughtful stories on MedCity News. Among this week's highlights, the technology innovations behind the growing electronic patient-reported outcomes market, NantHealth register for a $92 million IPO.
NantHealth files for IPO; here are 7 things we learned
NantHealth, the health IT, genomics and analytics division of Dr. Patrick Soon-Shiong's NantWorks operation, has finally filed for a long-awaited IPO.
With NaviNet in the fold, NantHealth looks to integration, IPO
Dr. Patrick Soon-Shiong made it sound like he finally had all the pieces in place to create a healthcare analytics and precision-medicine powerhouse that incorporates genomics, health records, patient history and claims data to produce prospective, actionable decision support across the whole healthcare continuum.
NantHealth moves into payer realm with NaviNet purchase
The desire to include payers on the NantHealth platform apparently has long been part of Soon-Shiong's plan.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
NantHealth to delay IPO in face of tough market
Dr. Patrick Soon-Shiong confirmed the plan in an interview with the Los Angeles Times. His NantKwest immuno-oncology company has lost half its value since a July IPO.
NantHealth acquiring Chicago precision medicine startup Health Heritage
Dr. William Knaus, who created Health Heritage, has been executive director for clinical research informatics at NantHealth since September.
Two of Patrick Soon-Shiong’s NantWorks startups net $250M
Dr. Patrick Soon-Shiong has two more fundraises under his companies' belt: According to an SEC filing, immuno-oncology startup NantCell has raised $100 million and precision medicine startup NantOmics has raised $150 million.
5 must-read stories for the holiday weekend, from medical devices exempted by the FDA to Google’s competition in crowdsourcing public health
MedHeads won't be airing today and content is light due to the holiday weekend, but you can check out the top five stories from the week wherever you choose to relax. Happy Independence Day!
Allscripts invests $200M in Soon-Shiong’s NantHealth in software integration deal (updated)
In a joint press release, NantHealth and Allscripts said that they would jointly integrate their software via application provider interfaces